DocGo Inc. provided earnings guidance for the year 2024. The revenue expectation for 2024 base businesses going forward, medical transportation and non-migrant mobile health is $280 million to $300 million, in line with previous expectations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +2.89% | +9.22% | -42.75% |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.75% | 316M | |
-3.83% | 3B | |
0.00% | 1.88B | |
+25.79% | 1.85B | |
+64.22% | 683M | |
-7.25% | 461M | |
-10.45% | 196M | |
-15.75% | 132M | |
+1.92% | 67.85M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings Guidance for the Year 2024